Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
Clinical trial NCT03836040 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03836040
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-19
- Primary completion
- 2025-11-19
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.